Antibacterial Suture Market Size, Share, and Industry Analysis, By Type (Absorbable and Non-absorbable), By Coating (Triclosan, Chlorhexidine Diacetate, and Others), By Application (Orthopedics, Gynecology & Obstetrics, General Surgery, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

The antibacterial suture market is witnessing significant growth due to the increasing number of surgeries across the globe. These sutures are surgical threads that are treated or coated with antimicrobial agents such as triclosan, chlorhexidine diacetate, and silver nanoparticles to reduce the risk of surgical site infections (SSIs). These sutures play a crucial role in preventing bacterial growth at the wound site, making them particularly beneficial in various surgical procedures, including general, orthopedic, and other soft tissue surgeries.

The increasing prevalence of chronic conditions, such as cardiovascular and orthopedic disorders, is leading to a rise in surgical procedures among patients.

• According to the 2022 data published by the Australian Bureau of Statistics (ABS) National Health Survey (NHS), around 7.3 million people are estimated to be living with chronic musculoskeletal conditions in Australia. Among these people, about 3.7 million people were estimated to be living with arthritis among the patient population. This higher prevalence can increase the demand for joint replacement surgeries. This surge in surgeries is contributing to a growing number of surgical wounds, which in turn drives the demand for antimicrobial sutures in the market.

Antibacterial Suture Market Driver

Increasing Number of Surgical Site Infections to Boost the Market

Antibacterial sutures are designed to prevent the growth of bacteria on the suture material and in  surrounding tissue, reducing the risk of infections. There is a rise in surgical procedures being performed globally and a corresponding increase in the number of surgical site infections. This is expected to increase the awareness and adoption of antibacterial sutures in the near future.

• For instance, in November 2022, according to a report published by the Centers for Disease Control and Prevention (CDC),  Methicillin-resistant Staphylococcus aureus (MRSA) by 14.0%, ventilator-associated events (VAE) by 12.0%, central line-associated bloodstream infection (CLABSI) by 7.0% and catheter-associated urinary tract infection (CAUTI) by 5.0% between 2020 and 2021. This increase is expected to escalate the demand for antibacterial sutures as awareness increases.

Download Free sample to learn more about this report.

Antibacterial Suture Market Restraint

Alternative Wound Closure Methods to Limit Market Growth

The presence of various alternative wound closure devices, such as staplers, can limit the market share of antibacterial sutures. Additionally, significant developments and advancements in staplers would increase the use of staplers over sutures, especially in developed markets.

• For instance, in June 2022, Johnson & Johnson Services, Inc. launched the ECHELON 3000 Stapler in the U.S. The device is a digitally enabled device that provides surgeons with simple, one-handed powered articulation. Such developments may limit the adoption of alternative options.

Antibacterial Suture Market Opportunity

Soaring Demand for Effective Sutures Create Opportunities for Industry Expansion

The increase in the prevalence of surgical site infections leads to the rising demand for effective sutures that provide effective sterility to the surgical site. Furthermore, the awareness regarding the necessity of sterility in emerging countries is expected to increase the adoption of antibacterial sutures in the near future, creating a lucrative opportunity.

• As per an article published in BMC Surgery in May 2020, Ethiopia had a higher surgical site infections with pooled prevalence of 12.3%. Such high prevalence is expected to increase the demand for antimicrobial suture in emerging countries to reduce the post-operative infection rate.

Furthermore, awareness regarding the necessity of sterility in emerging countries is expected to increase the adoption of antibacterial sutures in the near future, creating a lucrative opportunity.

Segmentation

Key Insights

The report covers the following key insights:

• Overview: List of Key Antimicrobial Sutures
• Number of Key Procedures, By Key Countries, 2023
• New Product Launches, By Key Players
• Overview: Technological Advancements in Antibacterial Sutures
• Key Industry Developments - (Mergers, Acquisitions, and Partnerships)
• Impact of COVID-19 on the Market

Analysis by Type

Based on type, the market is segmented into absorbable and non-absorbable.

The absorbable segment accounted for a significant revenue in the market. These sutures offer significant advantages, including high tensile strength that supports wound healing and a quicker recovery time. Furthermore, the growing acceptance of absorbable sutures by the regulatory bodies expected to drive the market further in the near future.

• For instance, in June 2021, the National Institute for Health and Care Excellence (NICE) recommended the use of absorbable suture with antibacterial properties to control infections and enhance healing.

Analysis by Coating

In terms of coating, the market for antibacterial suture is categorized into triclosan, chlorhexidine diacetate, and others.

The triclosan segment generated significant revenue in the market. Triclosan is a well-studied molecule for its antibacterial activity. The broad-spectrum antibacterial activity of triclosan is one of the major factors that enable players to use it to coat the suture, which increases the adoption of these products and drives market growth.

• For instance, an article published in Joint Diseases and Related Surgery in April 2023 stated that triclosan is a widely used antimicrobial agent, the suture which shows higher antibacterial activity.

Such studies support the effectiveness of triclosan which is expected to increase its adoption for coating in the near future.

Analysis by Application

Based on application, the market is categorized into orthopedics, gynecology & obstetrics, general surgery, and others.

The orthopedics segment accounted for a significant share of the market. The growth of the segment is attributed to the increasing aging population and age-related morbidities that require surgeries such as joint replacement and spinal surgeries. These factors are expected to drive the segment growth in the near future.

• For instance, the American College of Rheumatology published a report stating that each year, around 790,000 surgeries are conducted to replace knees, and over 450,000 surgeries are performed for hip replacements in the U.S. This number of procedures increases the demand for antimicrobial sutures to reduce surgical site infections.

Analysis by End-user

By end-user, the market is divided into hospital, specialty clinics, and others.

The hospitals segment accounted for a significant share in the market. The segment growth can be attributed to the increasing number of surgical procedures performed in the hospital, which increases the demand for antibacterial sutures to reduce surgical site infections. Additionally, the expansion of hospital chains is expected to result in more patient visits and a corresponding rise in the utilization of scar management treatments.

• For instance, in May 2024, Medcare Hospitals & Medical Centre expanded its network in the UAE with the opening of its new flagship hospital in Dubai. Such an increasing number of facilities is expected to increase the number of surgeries conducted, increasing the demand for antibacterial sutures.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the market in 2023. Factors such as the increasing number of surgical procedures that are being performed and associated surgical site infections, the growing focus on infection control, and advancements in surgical techniques are contributing to the market growth in the region.

• For instance, according to data from the Centers for Disease Control and Prevention (CDC), in 2021, the number of cesarean deliveries in the U.S. was 1,174,545. A larger number of these surgeries may require antibacterial suture to reduce the postoperative infection.

Asia Pacific region is expanding at a high CAGR during the study period. Rising focus on infection control, and an increasing number of emerging local players are the factors making the Asia Pacific region a potential market. Additionally, new product launches are expected to drive the market significantly in the near future. 

• In July 2022, Dolphin Sutures launched antibacterial suture line. This suture line has triclosan coating for the broad spectrum antibacterial property. This launch is expected to increase antimicrobial suture adoption in the region.

Latin America is expected to witness significant growth in the near future, driven by the higher number of cosmetic procedures conducted in Brazil and rising medical tourism in the region for various surgical procedures. Furthermore, increasing awareness about the importance of infection control and patient safety further boosts the market growth.

Key Players Covered

The global antibacterial suture market is fragmented, with the presence of several companies of various sizes. The report includes the profiles of the following key players:

• Johnson & Johnson Services, Inc. (U.S.)
• B. Braun SE (Germany)
• Dolphin Sutures (India)
• Lotus Surgicals Pvt Ltd (India)
• Meril Life Sciences Pvt. Ltd. (India)
• Samyang Holdings Corporation (South Korea)

Key Industry Developments

• In September 2023, Genesis MedTech, received approval from the China's National Medical Products Administration (NMPA) for the market release of its absorbable antimicrobial suture.
• In July 2022, Dolphin Sutures launched antibacterial suture line. This suture line has triclosan coating for the broad spectrum antibacterial property.
• In November 2020, Samyang Holdings Corporation launched Neosorb Plus in South Korea. It is an absorbable suture that are coated with chlorhexidine for an antibacterial property.